← All organizations

Hope Pharmaceuticals

For profitContributed to NMEWebsite ↗

Also known as: Hope Pharmaceuticals | HOPE PHARMS

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Jun 30, 2020

Timeline

2000s

Jan 1, 2000
Hope Pharmaceuticals— Founded

2010s

Jan 14, 2011
sodium nitrite— NDA Secondary Org
Feb 4, 2012
sodium nitrite— NDA Organization

Drugs by trial phase (3 distinct, 6 trials)

Phase 3 (1 own, 0 via acquisition)

sodium thiosulfate

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (2)

Recent trials (8)

NCT04401527Study directorPhase 2Jun 30, 2020
NCT04401527Lead sponsorPhase 2Jun 30, 2020
NCT03150420Study directorPhase 3May 24, 2017
NCT03150420Lead sponsorPhase 3May 24, 2017
NCT02176837Lead sponsorPhase 2Jun 1, 2014
NCT00873015Lead sponsorPhase 2Apr 1, 2010
NCT01033227CollaboratorPhase 1/Phase 2Dec 1, 2009
NCT00924118CollaboratorPhase 2Jul 1, 2009

Details

Founded: Scottsdale, AZ, US Jan 1, 2000
First NDA: Feb 4, 2012
Last known activity: Jun 30, 2020

Designations held

Orphan drug
Priority review